Royal Bank of Canada
ETTX

Royal Bank of Canada’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Royal Bank of Canada’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,000
Closed -$3K – 8182
2021
Q3 		$3K Buy
+1,000
New +$2.71K ﹤0.01% 7308
2020
Q2 		– Sell
-328
Closed -$1K – 7060
2020
Q1 		$1K Buy
328
+164
+100% +$739 ﹤0.01% 6557
2019
Q4 		$1K Hold
164
– – ﹤0.01% 6735
2019
Q3 		$1K Buy
+164
New +$1.1K ﹤0.01% 6577

Other funds holding ETTX

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Royal Bank of Canada's ETTX Position: Q4 2021 in Review

Royal Bank of Canada sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q4 2021, closing a stake of 1,000 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in ETTX in Q3 2019 and held it in 4 quarters. The position peaked at $3K in Q3 2021. 28 funds tracked by Wall St. Rank hold ETTX as of Q4 2021.

  • Royal Bank of Canada reported no remaining Entasis Therapeutics Holdings Inc. position as of Q4 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 1,000 Entasis Therapeutics Holdings Inc. shares in Q4 2021, an estimated $3K.
  • Royal Bank of Canada first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2019 and held it in 4 quarters.
  • Royal Bank of Canada's Entasis Therapeutics Holdings Inc. position peaked at $3K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q4 2021.

Based on Royal Bank of Canada's 13F filing for Q4 2021, filed 14 Feb 2022.